Recombinant perlecan domain V covalently immobilized on silk biomaterials via plasma immersion ion implantation supports the formation of functional endothelium

Author:

Lau Kieran12,Fu Lu1,Zhang Anyu3,Akhavan Behnam34567,Whitelock John1,Bilek Marcela M.3568,Lord Megan S.1,Rnjak‐Kovacina Jelena19ORCID

Affiliation:

1. Graduate School of Biomedical Engineering University of New South Wales Sydney New South Wales Australia

2. School of Chemistry, Chemical Engineering and Biotechnology Nanyang Technological University Singapore Singapore

3. School of Biomedical Engineering University of Sydney Sydney New South Wales Australia

4. School of Engineering University of Newcastle Callaghan New South Wales Australia

5. School of Physics University of Sydney Sydney New South Wales Australia

6. The University of Sydney Nano Institute, University of Sydney New South Wales Australia

7. Hunter Medical Research Institute (HMRI) New Lambton Heights New South Wales Australia

8. The Charles Perkins Center University of Sydney Sydney New South Wales Australia

9. Tyree Foundation Institute of Health Engineering Sydney New South Wales Australia

Abstract

AbstractStrategies to promote rapid formation of functional endothelium are required to maintain blood fluidity and regulate smooth muscle cell proliferation in synthetic vascular conduits. In this work, we explored the biofunctionalization of silk biomaterials with recombinantly expressed domain V of human perlecan (rDV) to promote endothelial cell interactions and the formation of functional endothelium. Perlecan is essential in vascular development and homeostasis and rDV has been shown to uniquely support endothelial cell, while inhibiting smooth muscle cell and platelet interactions, both key contributors of vascular graft failure. rDV was covalently immobilized on silk using plasma immersion ion implantation (PIII), a simple one‐step surface treatment process which enables strong immobilization in the absence of chemical cross‐linkers. rDV immobilization on surface‐modified silk was assessed for amount, orientation, and bio‐functionality in terms of endothelial cell interactions and functional endothelial layer formation. rDV immobilized on PIII‐treated silk (rDV‐PIII‐silk) supported rapid endothelial cell adhesion, spreading, and proliferation to form functional endothelium, as evidenced by the expression of vinculin and VE‐cadherin markers. Taken together, the results provide evidence for the potential of rDV‐PIII‐silk as a biomimetic vascular graft material.

Funder

Australian Research Council

NSW Health

University of New South Wales

Publisher

Wiley

Subject

Metals and Alloys,Biomedical Engineering,Biomaterials,Ceramics and Composites

Reference60 articles.

1. WHO.Cardiovascular diseases (CVDs); 2017. Accessed October 29 2017.http://www.who.int/cardiovascular_diseases/en/

2. Immunity, atherosclerosis and cardiovascular disease

3. BacharBJ MannaB.Coronary Artery Bypass Graft; 2022. Accessed January 28 2023.https://www.ncbi.nlm.nih.gov/books/NBK507836/

4. Fifty years of coronary artery bypass grafting

5. Advanced Silk Fibroin Biomaterials and Application to Small-Diameter Silk Vascular Grafts

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3